6,8-DICHLORO-3-PHENYL-2-THIOXO-2,3-DIHYDRO-4(1H)-QUINAZOLINONE
|
- $103 - $183
- Product name: 6,8-DICHLORO-3-PHENYL-2-THIOXO-2,3-DIHYDRO-4(1H)-QUINAZOLINONE
- CAS: 67867-62-3
- MF: C14H8Cl2N2OS
- MW: 323.2
- EINECS:
- MDL Number:MFCD08689694
- Synonyms:6,8-DICHLORO-3-PHENYL-2-THIOXO-2,3-DIHYDRO-4(1H)-QUINAZOLINONE;6,8-dichloro-3-phenyl-2-sulfanylidene-1H-quinazolin-4-one;4(1H)-Quinazolinone, 6,8-dichloro-2,3-dihydro-3-phenyl-2-thioxo-
3 prices
Selected condition：
Brand
- Matrix Scientific
- SynQuest Laboratories
Package
- 500mg
- 1g
- 5G
- ManufacturerMatrix Scientific
- Product number047006
- Product description6,8-Dichloro-3-phenyl-2-thioxo-2,3-dihydro-4(1H)-quinazolinone >95%
- Packaging500mg
- Price$118
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number8H67-5-10
- Product description6,8-Dichloro-2,3-dihydro-3-phenyl-2-thioxo-1H-quinazolin-4-one
- Packaging1g
- Price$103
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number8H67-5-10
- Product description6,8-Dichloro-2,3-dihydro-3-phenyl-2-thioxo-1H-quinazolin-4-one
- Packaging5G
- Price$183
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Matrix Scientific | 047006 | 6,8-Dichloro-3-phenyl-2-thioxo-2,3-dihydro-4(1H)-quinazolinone >95% | 500mg | $118 | 2021-12-16 | Buy |
| SynQuest Laboratories | 8H67-5-10 | 6,8-Dichloro-2,3-dihydro-3-phenyl-2-thioxo-1H-quinazolin-4-one | 1g | $103 | 2021-12-16 | Buy |
| SynQuest Laboratories | 8H67-5-10 | 6,8-Dichloro-2,3-dihydro-3-phenyl-2-thioxo-1H-quinazolin-4-one | 5G | $183 | 2021-12-16 | Buy |
Properties
Melting point :274-275°C
Boiling point :472.7±55.0 °C(Predicted)
Density :1.59±0.1 g/cm3(Predicted)
pka :9.68±0.20(Predicted)
Boiling point :472.7±55.0 °C(Predicted)
Density :1.59±0.1 g/cm3(Predicted)
pka :9.68±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|